258 related articles for article (PubMed ID: 16850106)
1. The role of 111indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas.
Nathoo N; Ugokwe K; Chang AS; Li L; Ross J; Suh JH; Vogelbaum MA; Barnett GH
J Neurooncol; 2007 Jan; 81(2):167-74. PubMed ID: 16850106
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imaging.
Alexandru D; Glantz MJ; Kim L; Chamberlain MC; Bota DA
Cancer; 2011 Oct; 117(19):4506-11. PubMed ID: 21446045
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.
Henze M; Schuhmacher J; Hipp P; Kowalski J; Becker DW; Doll J; Mäcke HR; Hofmann M; Debus J; Haberkorn U
J Nucl Med; 2001 Jul; 42(7):1053-6. PubMed ID: 11438627
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.
Henze M; Dimitrakopoulou-Strauss A; Milker-Zabel S; Schuhmacher J; Strauss LG; Doll J; Mäcke HR; Eisenhut M; Debus J; Haberkorn U
J Nucl Med; 2005 May; 46(5):763-9. PubMed ID: 15872348
[TBL] [Abstract][Full Text] [Related]
5. 111Indium-octreotide brain scintigraphy: a prognostic factor in skull base meningiomas treated with gamma knife radiosurgery.
Nicolato A
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):26-32. PubMed ID: 15195001
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive differentiation of meningiomas from other brain tumours using combined 111Indium-octreotide/99mtechnetium-DTPA brain scintigraphy.
Barth A; Haldemann AR; Reubi JC; Godoy N; Rösler H; Kinser JA; Seiler RW
Acta Neurochir (Wien); 1996; 138(10):1179-85. PubMed ID: 8955437
[TBL] [Abstract][Full Text] [Related]
7. Contribution of 68Ga-DOTATOC PET/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy.
Graf R; Nyuyki F; Steffen IG; Michel R; Fahdt D; Wust P; Brenner W; Budach V; Wurm R; Plotkin M
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):68-73. PubMed ID: 22575489
[TBL] [Abstract][Full Text] [Related]
8. 13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report.
Xiangsong Z; Xingchong S; Chang Y; Xiaoyan W; Zhifeng C
Clin Nucl Med; 2011 Nov; 36(11):1003-6. PubMed ID: 21975388
[TBL] [Abstract][Full Text] [Related]
9. High sensitivity of the in vivo detection of somatostatin receptors by 111indium (DTPA-octreotide)-scintigraphy in meningioma patients.
Hildebrandt G; Scheidhauer K; Luyken C; Schicha H; Klug N; Dahms P; Krisch B
Acta Neurochir (Wien); 1994; 126(2-4):63-71. PubMed ID: 8042557
[TBL] [Abstract][Full Text] [Related]
10. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
[TBL] [Abstract][Full Text] [Related]
11. Correlation between 99mTc-HYNIC-octreotide SPECT/CT somatostatin receptor scintigraphy and pathological grading of meningioma.
Wang S; Yang W; Deng J; Zhang J; Ma F; Wang J
J Neurooncol; 2013 Jul; 113(3):519-26. PubMed ID: 23657621
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of 24-hour delayed imaging in somatostatin receptor scintigraphy for meningioma.
Klutmann S; Bohuslavizki KH; Tietje N; Kröger S; Behnke A; Brenner W; Mester J; Henze E; Clausen M
J Nucl Med; 1999 Aug; 40(8):1246-51. PubMed ID: 10450673
[TBL] [Abstract][Full Text] [Related]
13. Molecular biologic and scintigraphic analyses of somatostatin receptor-negative meningiomas.
Meewes C; Bohuslavizki KH; Krisch B; Held-Feindt J; Henze E; Clausen M
J Nucl Med; 2001 Sep; 42(9):1338-45. PubMed ID: 11535722
[TBL] [Abstract][Full Text] [Related]
14. Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.
Acker G; Kluge A; Lukas M; Conti A; Pasemann D; Meinert F; Anh Nguyen PT; Jelgersma C; Loebel F; Budach V; Vajkoczy P; Furth C; Baur ADJ; Senger C
Neurosurg Focus; 2019 Jun; 46(6):E9. PubMed ID: 31153151
[TBL] [Abstract][Full Text] [Related]
15. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
[TBL] [Abstract][Full Text] [Related]
16. 1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery.
Liu RS; Chang CP; Guo WY; Pan DH; Ho DM; Chang CW; Yang BH; Wu LC; Yeh SH
J Nucl Med; 2010 Jun; 51(6):883-91. PubMed ID: 20484430
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor scintigraphy for optic nerve sheath meningiomas.
Saeed P; Tanck MW; Freling N; Baldeschi L; Mourits MP; Bennink RJ
Ophthalmology; 2009 Aug; 116(8):1581-6. PubMed ID: 19500849
[TBL] [Abstract][Full Text] [Related]
18. A radiopathological classification of dural tail sign of meningiomas.
Qi ST; Liu Y; Pan J; Chotai S; Fang LX
J Neurosurg; 2012 Oct; 117(4):645-53. PubMed ID: 22839654
[TBL] [Abstract][Full Text] [Related]
19. Comparison of diagnostic value of 68 Ga-DOTATOC PET/MRI and standalone MRI for the detection of intracranial meningiomas.
Einhellig HC; Siebert E; Bauknecht HC; Tietze A; Graef J; Furth C; Schulze D; Miszczuk M; Bohner G; Schatka I; Makowski MR
Sci Rep; 2021 Apr; 11(1):9064. PubMed ID: 33907204
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
